191 related articles for article (PubMed ID: 20061933)
1. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
2. Endocervical glandular lesions: controversial aspects and ancillary techniques.
McCluggage WG
J Clin Pathol; 2003 Mar; 56(3):164-73. PubMed ID: 12610091
[TBL] [Abstract][Full Text] [Related]
3. False-Positive Atypical Endocervical Cells in Conventional Pap Smears: Cyto-Histological Correlation and Analysis.
Pulkkinen J; Huhtala H; Kholová I
Acta Cytol; 2023; 67(6):604-617. PubMed ID: 37562375
[TBL] [Abstract][Full Text] [Related]
4. From morphology to methylome: epigenetic studies of Müllerian mesonephric-like adenocarcinoma reveal similarities to cervical mesonephric adenocarcinoma
Lin LH; Howitt BE; Kolin DL
J Pathol; 2024 Jun; 263(2):135-138. PubMed ID: 38593211
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in invasive adenocarcinoma of the cervix.
Stolnicu S; Hoang L; Soslow RA
Virchows Arch; 2019 Nov; 475(5):537-549. PubMed ID: 31209635
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Combined Serous Borderline Tumor/Low-grade Serous Carcinoma and Mesonephric-like Lesion: Report of 2 Cases With New Observations.
Nilforoushan N; Liu L; Finkelman BS; Andersen J; Liu Y; James J; Hung CF; Wu TC; Vang R; Xing D
Int J Gynecol Pathol; 2023 Mar; 42(2):182-191. PubMed ID: 35348533
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
Ji N; Lee Y; Lee SH; Kim HS
Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751
[TBL] [Abstract][Full Text] [Related]
8. Mixed Mesonephric-like Adenocarcinoma, Clear Cell Carcinoma, and Endometrioid Carcinoma Arising from an Endometriotic Cyst.
Nagase S; Saeki H; Ura A; Terao Y; Matsumoto T; Yao T
Int J Surg Pathol; 2023 Nov; ():10668969231213390. PubMed ID: 37994045
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma.
Lee Y; Choi S; Kim HS
Int J Gynecol Pathol; 2024 May; 43(3):221-232. PubMed ID: 37566876
[TBL] [Abstract][Full Text] [Related]
10. Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix.
Kommoss FK; Lee CH; Tessier-Cloutier B; Gilks CB; Stewart CJ; von Deimling A; Köbel M
J Pathol; 2024 Jan; 262(1):4-9. PubMed ID: 37850576
[TBL] [Abstract][Full Text] [Related]
11. Cytologic features of upper gynecologic tract adenocarcinomas exhibiting mesonephric-like differentiation.
Kezlarian B; Muller S; Werneck Krauss Silva V; Gonzalez C; Fix DJ; Park KJ; Murali R
Cancer Cytopathol; 2019 Aug; 127(8):521-528. PubMed ID: 31318491
[TBL] [Abstract][Full Text] [Related]
12. Endometrioid type adenocarcinoma in situ as a potential precursor lesion for extremely rare invasive endometrioid type adenocarcinoma of the cervix.
Zannoni GF; Santoro A; Addante F; Cianfrini F; Stolnicu S
Pathol Res Pract; 2024 Feb; 254():155062. PubMed ID: 38199133
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of goblet cell metaplasia in endocervical and endometrial adenocarcinoma : a histochemical study.
Nieuwenhuizen L; Khalil MK; Naik VR; Othman NH
Malays J Med Sci; 2007 Jan; 14(1):56-61. PubMed ID: 22593653
[TBL] [Abstract][Full Text] [Related]
14. Atypical lobular endocervical glandular hyperplasia: two case report and literature review.
Wan Z; Liu S; Sang N; Tang Y; Wen P; Zhang P; Shu C
Front Oncol; 2023; 13():1298793. PubMed ID: 38115903
[TBL] [Abstract][Full Text] [Related]
15. [Mesonephric lesions of female genital tract: An overview from benign tumors to emerging malignancy].
Trecourt A; Boujida I; Devouassoux-Shisheboran M
Ann Pathol; 2023 Nov; 43(6):431-442. PubMed ID: 37481413
[TBL] [Abstract][Full Text] [Related]
16. Gastric-type adenocarcinoma of the uterine cervix presenting in urine cytology specimens: A case report and literature review.
Lee KH; Kim NI; Nam JH; Kim SS
Diagn Cytopathol; 2024 Apr; 52(4):E80-E83. PubMed ID: 38140795
[TBL] [Abstract][Full Text] [Related]
17. Cervical malignant mixed mesonephric tumour: A case report with local recurrence after six-years and next-generation sequencing analysis with particular reference to the ataxia telangiectasia mutated gene.
Marani C; Akaev I; Yeoh CC; Walsh E; Rahimi S
Exp Ther Med; 2021 Apr; 21(4):394. PubMed ID: 33680116
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Adenocarcinoma, HPV-independent, Mesonephric Type with Significant Response to Neoadjuvant Chemotherapy].
Kuratsune K; Ueda T; Tajiri R; Tohyama A; Hoshino K; Harada H; Kurita T; Kubo C; Komatsu K; Shiba E; Matsuura Y; Yoshino K
J UOEH; 2024; 46(1):45-51. PubMed ID: 38479874
[TBL] [Abstract][Full Text] [Related]
19. Mucinous cystadenoma and benign mesonephric-like proliferation in the ovary - Further evidence for clonal relationship.
Hiller GGR; Höhn AK; Krücken I; Monecke A; Reske D; Brambs CE; Horn LC
Pathol Res Pract; 2024 May; 258():155336. PubMed ID: 38723326
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Clinicopathological and Prognostic Characteristics Between Minimal Deviation Adenocarcinoma and Gastric-type Endocervical Adenocarcinoma.
Kum SJ; Jung YY; Kim HS
Anticancer Res; 2024 May; 44(5):2193-2204. PubMed ID: 38677732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]